Resources

Drugs to be avoided for use in patients with diagnosed or suspected congenital long QT syndrome

References

1. Ackerman MJ. Cardiac Channelopathies: It’s in the Genes. Nature Medicine 2004;10:463-464.
2. Antzelevitch C, Bridge P, Brugada J, et al. Brugada Syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 2003;41:1665-1671.
3. Keating MT and Sanguinetti MC. Molecular and Cellular Mechanisms of Cardiac Arrhythmias. Cell 2001;104:569-580.
4. Kimbrough J, Moss AJ, Zareba W, et al. Clinical Implications for Affected Parents and Siblings of Probands With Long-QT Syndrome. Circulation 2001;104:557-562.
5. Marban E. Cardiac Channelopathies. Nature 2002;415:213-218.
6. Maron BJ, Chair; Moller JH, Cochair; Seidman CE; et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome. – A statement for health care professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, by the American Heart Association. Circulation 1998;98:1460-1471.
7. Mohammed U, Napolitano C, Priori SG. Molecular and electrophysiological basis of catecholaminergic polymorphic ventricular tachycardia.  J Cardiovasc Electrophysiol. 2007;18(7):791-797.
8. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and Limitations of b-Blocker Therapy in Congenital Long-QT Syndrome. Circulation 2000;101:616-623.
9. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:675-678.
10. Priori SG, Napolitano C, et al. Clinical and molecular characteristics of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.
11. Priori SG, Napolitano C and Schwartz PJ. Low Penetrance in the Long-QT Syndrome. Circulation 1999;99:529-533.
12. Priori SG, Schwartz PJ, Napolitano C, et al. Risk Stratification in the Long-QT Syndrome. N Engl J Med 2003;348:1866-1874.
13. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-Phenotype Correlation in the Long-QT Syndrome, Gene-Specific Triggers for Life-Threatening Arrhythmias. Circulation 2001;103:89-95.
14. Vincent, MG. The Long-QT Syndrome-Bedside to Bench to Bedside. N Engl J Med 2003;348:1837-1838.
15. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome. N Engl J Med 1998;339:960-965.

Links

Sudden Arrhythmia Death Syndrome
www.sads.org

Cardiac Arrhythmias Research and Education Foundation
www.longqt.org

Ramon Brugada Senior Foundation
www.brugada.org

The National SIDS/Infant Death Resource Center
www.sidscenter.org

National Society of Genetic Counselors
www.nsgc.org

Heart Rhythm Society
www.HRSonline.org

American Heart Association
www.americanheart.org

Hypertrophic Cardiomyopathy Association
http://www.4hcm.org/

Children's Cardiomyopathy Foundation
www.childrenscardiomyopathy.org

Hannah Wernke Memorial Foundation
http://www.hannahwernkememorialfoundation.com/

1-877-2-PGXHEALTH (877-274-9432)